These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28482292)

  • 1. New drugs for the treatment of Mycobacterium tuberculosis infection.
    AlMatar M; AlMandeal H; Var I; Kayar B; Köksal F
    Biomed Pharmacother; 2017 Jul; 91():546-558. PubMed ID: 28482292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming the tuberculosis drug pipeline: new antimycobacterial targets and agents.
    Evans JC; Mizrahi V
    Curr Opin Microbiol; 2018 Oct; 45():39-46. PubMed ID: 29482115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets.
    Hudson SA; McLean KJ; Munro AW; Abell C
    Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance mechanisms and novel drug targets for tuberculosis therapy.
    Islam MM; Hameed HMA; Mugweru J; Chhotaray C; Wang C; Tan Y; Liu J; Li X; Tan S; Ojima I; Yew WW; Nuermberger E; Lamichhane G; Zhang T
    J Genet Genomics; 2017 Jan; 44(1):21-37. PubMed ID: 28117224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.
    Sacchettini JC; Rubin EJ; Freundlich JS
    Nat Rev Microbiol; 2008 Jan; 6(1):41-52. PubMed ID: 18079742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and bioactivity of antitubercular peptides and peptidomimetics: an update.
    De Leon Rodriguez LM; Kaur H; Brimble MA
    Org Biomol Chem; 2016 Jan; 14(4):1177-87. PubMed ID: 26645944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of new anti-tuberculosis drug candidates.
    Shi R; Sugawara I
    Tohoku J Exp Med; 2010 Jun; 221(2):97-106. PubMed ID: 20467231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes.
    Xu Y; Wu J; Liao S; Sun Z
    Ann Clin Microbiol Antimicrob; 2017 Oct; 16(1):67. PubMed ID: 28974222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bottlenecks and opportunities in antibiotic discovery against Mycobacterium tuberculosis.
    Craggs PD; de Carvalho LPS
    Curr Opin Microbiol; 2022 Oct; 69():102191. PubMed ID: 35970040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
    Di Perri G; Bonora S
    J Antimicrob Chemother; 2004 Sep; 54(3):593-602. PubMed ID: 15282233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could Killing Bacterial Subpopulations Hit Tuberculosis out of the Park?
    Baranowski C; Rubin EJ
    J Med Chem; 2016 Jul; 59(13):6025-6. PubMed ID: 27322073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection caused by Mycobacterium tuberculosis.
    Peloquin CA; Berning SE
    Ann Pharmacother; 1994 Jan; 28(1):72-84. PubMed ID: 8123968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer patents in antimycobacterial therapy.
    Shahid SK
    Pharm Pat Anal; 2015; 4(3):219-38. PubMed ID: 26030082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational medicinal chemistry for rational drug design: Identification of novel chemical structures with potential anti-tuberculosis activity.
    Koseki Y; Aoki S
    Curr Top Med Chem; 2014; 14(1):176-88. PubMed ID: 24236720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis... Can we beat it? Report from a Euroscicon conference 2013.
    Maitra A; Bhakta S
    Virulence; 2013 Aug; 4(6):499-503. PubMed ID: 23863609
    [No Abstract]   [Full Text] [Related]  

  • 20. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening.
    Manjunatha UH; Smith PW
    Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.